Compare AFCG & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFCG | ALPS |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.4M | 66.6M |
| IPO Year | 2020 | 2024 |
| Metric | AFCG | ALPS |
|---|---|---|
| Price | $3.07 | $0.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 61.9K | 47.7K |
| Earning Date | 11-11-2026 | 07-24-2026 |
| Dividend Yield | ★ 6.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $24,563,601.00 | N/A |
| Revenue This Year | $1,384.82 | N/A |
| Revenue Next Year | $1.29 | N/A |
| P/E Ratio | $4.25 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.06 | $0.23 |
| 52 Week High | $3.84 | $1.72 |
| Indicator | AFCG | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 35.07 | 37.08 |
| Support Level | $3.08 | $0.23 |
| Resistance Level | $3.66 | $0.44 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 12.32 | 22.10 |
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.